<?xml version="1.1" encoding="utf-8"?>
<rdf:RDF xmlns:OMEXlib="http://omex-library.org/"
   xmlns:bqbiol="http://biomodels.net/biology-qualifiers/"
   xmlns:bqmodel="http://biomodels.net/model-qualifiers/"
   xmlns:dc="http://purl.org/dc/terms/"
   xmlns:foaf="http://xmlns.com/foaf/0.1/"
   xmlns:local="http://omex-library.org/NewOmex.omex/NewModel.rdf#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="http://omex-library.org/BIOMD0000001025.omex">
    <bqmodel:isDescribedBy rdf:resource="local:00001"/>
    <ns1:keyword xmlns:ns1="http://prismstandard.org/namespaces/basic/2.0/">Biomodels</ns1:keyword>
    <ns2:description xmlns:ns2="http://purl.org/dc/elements/1.1/">&lt;body xmlns="http://www.w3.org/1999/xhtml"&gt;
  &lt;pre&gt;This ordinary differential equation model of the cellular kinetics and pharmacodynamics of CAR-T cell therapy is described in the publication:
Chaudhury, A., Zhu, X., Chu, L., Goliaei, A., June, C., Kearns, J. and Stein, A., 2020. Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic‚ÄêPharmacodynamic Modeling Approaches. The Journal of Clinical Pharmacology, 60(S1).
DOI: 10.1002/jcph.1691

Comment:
This model is based on equations 7-9 from the manuscript.

Abstract:
Chimeric antigen receptor T cell (CAR-T cell) therapies have shown significant efficacy in CD19+ leukemias and lymphomas. There remain many challenges and questions for improving next-generation CAR-T cell therapies, and mathematical modeling of CAR-T cells may play a role in supporting further development. In this review, we introduce a mathematical modeling taxonomy for a set of relatively simple cellular kinetic-pharmacodynamic models that describe the in vivo dynamics of CAR-T cell and their interactions with cancer cells. We then discuss potential extensions of this model to include target binding, tumor distribution, cytokine-release syndrome, immunophenotype differentiation, and genotypic heterogeneity.&lt;/pre&gt;
&lt;/body&gt;</ns2:description>
    <ns3:title xmlns:ns3="http://purl.org/dc/elements/1.1/">Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic-Pharmacodynamic Modeling Approaches</ns3:title>
    <ns4:thumbnail xmlns:ns4="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001025.omex/Fig 3(A) - Biphasis CAR-T cell kinetics with cure.png"/>
    <ns5:thumbnail xmlns:ns5="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001025.omex/Fig 3(B) - Biphasis CAR-T cell kinetics with relapse.png"/>
    <ns6:thumbnail xmlns:ns6="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001025.omex/Fig 4(A) - EC50 expansion B cells.png"/>
    <ns7:thumbnail xmlns:ns7="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001025.omex/Fig 4(A) - EC50 expansion CAR-T cells.png"/>
    <ns8:thumbnail xmlns:ns8="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001025.omex/Fig 4(B) - EC50 expansion B cells.png"/>
    <ns9:thumbnail xmlns:ns9="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001025.omex/Fig 4(B) - EC50 expansion CAR-T cells.png"/>
    <ns10:thumbnail xmlns:ns10="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000001025.omex/curation_image.png"/>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <ns11:identifier xmlns:ns11="http://purl.org/dc/elements/1.1/"
       rdf:resource="http://identifiers.org/doi/10.1002/jcph.1691"/>
    <ns12:label xmlns:ns12="http://www.w3.org/2000/01/rdf-schema#">Anwesha Chaudhury, Xu Zhu, Lulu Chu, Ardeshir Goliaei, Carl H. June, Jeffrey D. Kearns &amp; Andrew M. Stein. Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic-Pharmacodynamic Modeling Approaches. The Journal of Clinical Pharmacology 60 Suppl 1 (2020).</ns12:label>
  </rdf:Description>
</rdf:RDF>

